Bvf Inc Monte Rosa Therapeutics, Inc. Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
A detailed history of Bvf Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,660,132 shares of GLUE stock, worth $21.9 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
5,660,132
Previous 2,764,471
104.75%
Holding current value
$21.9 Million
Previous $19.2 Million
36.89%
% of portfolio
1.15%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding GLUE
# of Institutions
106Shares Held
53.3MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$29.8 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$25.7 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$21.9 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$19 Million0.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.65MShares$18 Million0.35% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $181M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...